Practice variations in indication, timing and outcome of Multiple Myeloma patients undergoing surgery for vertebral lesions – results from the European M2Spine study group - Top-Institutions - MDSpire

Practice variations in indication, timing and outcome of Multiple Myeloma patients undergoing surgery for vertebral lesions – results from the European M2Spine study group

  • By

  • Vanessa Hubertus

  • Lennart Viezens

  • Martin Stangenberg

  • Anton M. Früh

  • Hanno S. Meyer

  • Raimunde Liang

  • Andreas Kramer

  • Christoph Orban

  • Johannes Kerschbaumer

  • Beate Kunze

  • Stefano Telera

  • Hannah Miller

  • Christian J. Entenmann

  • Emily J. von Bronewski

  • Charlotte Buhre

  • Leon-Gordian Leonhardt

  • Wolfgang Willenbacher

  • Irma Kvitsaridze

  • Dominik Laue

  • Matthias Pumberger

  • Theresa Keller

  • Güliz Acker

  • Jan Krönke

  • Igor-Wolfgang Blau

  • Ulrich Keller

  • Florian Ringel

  • Claudius Thomé

  • Bernhard Meyer

  • Peter Vajkoczy

  • Marc Dreimann

  • Julia Sophie Onken

  • June 13, 2025

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology-Oncology
    • Orthopedic Spine Surgery
    • Musculoskeletal Oncology

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Hematology-Oncology
    • Neurosurgery
    • Orthopedic Surgery

  • #3

    University Hospital Heidelberg
    University Hospital Heidelberg

    Heidelberg, Baden-Württemberg

    Key Differentiators

    • Hematology-Oncology
    • Spine Surgery
    • Oncologic Orthopedics

  • #4

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Hematology-Oncology
    • Neurosurgery
    • Orthopedic Surgery

  • #5

    Charité – Universitätsmedizin Berlin
    Charité – Universitätsmedizin Berlin

    Berlin, Berlin

    Key Differentiators

    • Hematology-Oncology
    • Spine Surgery
    • Orthopedic Oncology

Original Source(s)

Practice variations in indication, timing and outcome of Multiple Myeloma patients undergoing surgery for vertebral lesions – results from the European M2Spine study group

  • by Vanessa Hubertus, Lennart Viezens, Martin Stangenberg, Anton M. Früh, Hanno S. Meyer, Raimunde Liang, Andreas Kramer, Christoph Orban, Johannes Kerschbaumer, Beate Kunze, Stefano Telera, Hannah Miller, Christian J. Entenmann, Emily J. von Bronewski, Charlotte Buhre, Leon-Gordian Leonhardt, Wolfgang Willenbacher, Irma Kvitsaridze, Dominik Laue, Matthias Pumberger, Theresa Keller, Güliz Acker, Jan Krönke, Igor-Wolfgang Blau, Ulrich Keller, Florian Ringel, Claudius Thomé, Bernhard Meyer, Peter Vajkoczy, Marc Dreimann, Julia Sophie Onken

  • June 13, 2025

Related Content

Efficacy of Quadruplet Therapy with Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone as Initial Treatment for High-Risk Multiple Myeloma Patients in China: Findings from a Multi-Center Real-World Study

Experiences and expert panel consensus on bridging therapy before anti-BCMA CAR-T cell therapy in multiple myeloma

Dana-Farber Team Develops Open-Access Predictive Tool to Improve Monitoring of Smoldering Multiple Myeloma

The tool, called PANGEA-SMM, outperforms existing predictive tools by more accurately determining when smoldering multiple myeloma is progressing and requires treatment. The free online tool can be used immediately to monitor patients.

  • by

  • March 24, 2026

  • 5 min